Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Haemonetics Corp (NY: HAE )

74.97 +0.52 (+0.70%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 711,162
Open 74.63
Bid (Size) 74.37 (1)
Ask (Size) 75.30 (1)
Prev. Close 74.45
Today's Range 74.32 - 75.74
52wk Range 70.74 - 97.97
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Despite its growth, NYSE:HAE remains within the realm of affordability.
HAEMONETICS CORP/MASS (NYSE:HAE), a growth stock which is not overvalued. 
Via Chartmill
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
From Aligos Therapeutics
Via GlobeNewswire

Performance

YTD
-11.95%
-11.95%
1 Month
+3.48%
+3.48%
3 Month
-17.23%
-17.23%
6 Month
-12.03%
-12.03%
1 Year
-14.51%
-14.51%

More News

Read More
NYSE:HAE stands out as a growth opportunity that won't break the bank.
Via Chartmill
What Analysts Are Saying About Haemonetics Stock
Via Benzinga
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
Via Chartmill
Analyst Expectations For Haemonetics's Future
Via Benzinga
NYSE:HAE stands out as a growth opportunity that won't break the bank.
Via Chartmill
Looking for growth without the hefty price tag? Consider NYSE:HAE.
Via Chartmill
Top 3 Health Care Stocks That Are Set To Fly This Quarter
Via Benzinga
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
Via Chartmill
Sotera Health Appoints Christopher Simon to the Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
Via Benzinga
This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
NYSE:HAE, a growth stock which is not overvalued.
Via Chartmill
4 Analysts Assess Haemonetics: What You Need To Know
Via Benzinga
Earnings Scheduled For February 8, 2024
Via Benzinga
These 3 Companies Boast Bright Outlooks
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
Via InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
Via Chartmill
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Via Investor's Business Daily
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
Via Investor's Business Daily
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.